RSS

ACTX Advanced Container Technologies Inc.

Last Post: 10/17/23
Followers: 25
Posts Today: 0
Views Today: 1959

ACTX Stock Quote & Tools

$0.0001 ▲ +0.0000 (+0.00%) As of Nov 3, 9:31 AM EST
Last0.0001
$ Chg0.0000
Open—
High—
Beta33.3292
Year High0.000
Market Cap5.2K
P/B Ratio0.00
EPS-0.03
Avg Vol (30d)23
Volume0
% Chg+0.00%
Prev Close0.0001
Low—
VWAP—
Year Low0.000
Total Shares51.90M
Shares Out51.90M
Float34.57M
ExchangeOTCID
Consumer Discretionary Containers & Packaging

ACTX Stock Message Board Discussion

Top 10 Most Recent News Articles

Four Pending Deals Put Shareholder Terms Under Scrutiny

Updated Category News Views 55

Four corporate transactions landed under a legal microscope on November 18, and that is never background noise for shareholders trying to judge whether the paperwork matches the price. Halper Sadeh LLC says it is investigating proposed deals involving WaFd, Personalis, Dana and Baldwin Group for possible federal securities-law violations and/or fiduciary-duty breaches....

Continue Reading
Health In Tech Brings a Tech Veteran Onto Its Board

Updated Category News Views 7

Board appointments rarely make the cash register ring, but they can tell you where management thinks the next bruises are coming from. Health In Tech has added Tim Cortes as an independent director, put him in charge of the Compensation Committee, and placed him on both the Audit and Nominating and Corporate Governance Committees. For an AI-enabled insurance technology...

Continue Reading
Qonto's Banking License Raises the Stakes in Europe

Updated Category News Views 56

A regulatory stamp can look dull on paper, yet this one changes the machinery underneath Qonto. The Paris-based finance platform has received a Credit Institution license from France's ACPR and the European Central Bank, giving it a route to offer broader lending and savings products directly to small and midsize businesses across Europe. That is a serious corporate...

Continue Reading
Clorox Boosts Payout With Steady $1.25 Dividend

Updated Category News Views 190

Quarterly Dividends: A Clorox Tradition It seems you can't talk about Clorox (NYSE: CLX) without mentioning its steadfast dedication to shareholders. Once again, this 113-year-old stalwart is back on the map with its juicy quarterly dividend—$1.25 per share, to be precise. That's scheduled to hit your account by February 12, 2027, if you're on the books by the end of...

Continue Reading
Animal Parasite Market Growth Has a Resistance Catch

Updated Category News Views 156

Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...

Continue Reading
Watson Motion Tests Military Pretrial Confinement Rules

Updated Category News Views 39

Military confinement fights are rarely neat, and this one comes with a short clock but plenty of unanswered questions. Defense lawyers for U.S. Air Force Maj. Jason Watson argued on Nov. 17 that he should be released from pretrial confinement while his case proceeds. A military judge is ordinarily expected to issue a ruling within 14 days of the hearing, under the court's...

Continue Reading
DEFSEC Tackles Nasdaq Bid Price Hurdle with Share Move

Updated Category News Views 68

Navigating Bid Price Deficiency Issues Well, it seems DEFSEC Technologies Inc. found themselves in a tricky spot last week. A nasty gram from Nasdaq’s Listing Qualifications Department pointing out that DEFSEC's shares had dipped below that $1.00 per share requirement for too long—a full 30 business days. Now, don't panic just yet. This isn't about the shares getting...

Continue Reading
Chaos Zero Nightmare's Award Is a Useful Signal for Games

Updated Category News Views 232

A story award can be easy to sneer at until a live-service game earns one across three markets. Smilegate's Chaos Zero Nightmare, a dark fantasy roguelike RPG developed by Super Creative, was named Best Story in Google Play's Best of 2026 awards for Taiwan, Hong Kong and Macau. That is not a sales figure, not a profit disclosure, and certainly not proof that a hit has...

Continue Reading
Stand Out For Good Makes a Bold Michigan Avenue Bet

Updated Category News Views 183

A six-floor retail commitment lands with a thud Stand Out For Good is taking on roughly 51,079 square feet at 669 North Michigan Avenue, and nobody should mistake that for a casual expansion. Six levels on Chicago's Magnificent Mile is a proper declaration of intent, especially in a retail district that has endured plenty of empty-window handwringing and big-brand churn....

Continue Reading
AMP Tests Debt Market With €1.25 Billion Green Notes

Updated Category News Views 62

Refinancing season has arrived early at Ardagh Metal Packaging, and it is carrying a hefty €1.25 billion price tag. AMP has launched senior secured floating-rate green notes, with proceeds intended to retire two batches of secured debt due in 2028 and leave additional cash on the balance sheet for general corporate purposes, including capital expenditure. This is not...

Continue Reading

Top 5 Most Recently Viewed Articles

Dover Set to Release Q2 2025 Earnings; Join the Conference Call

Updated Category News Views 156

Dover Set to Release Q2 2025 Earnings Dover is gearing up to share its financial results for the second quarter of 2025, scheduled for release at approximately 6:00 a.m. Central time on the upcoming Thursday. This significant event marks a crucial moment for shareholders and analysts alike, as they anticipate insights into the company's performance and strategic moves....

Continue Reading
Investigation of ImmunityBio, Inc. and Shareholder Rights

Updated Category News Views 322

Investigation of ImmunityBio, Inc. In recent developments, Bragar Eagel & Squire, P.C., a well-respected law firm specializing in shareholder rights, has launched an investigation regarding ImmunityBio, Inc. (NASDAQ: IBRX). This probe is geared towards looking into potential legal claims on behalf of long-term shareholders, aiming to ensure their interests are safeguarded...

Continue Reading
Norges Bank's Recent Stake Change in Syensqo Explained

Updated Category News Views 279

Norges Bank's Recent Notification Regarding Stake in Syensqo Norges Bank has recently communicated a significant change regarding its participation in Syensqo. This notification, in line with Belgian transparency laws, reveals that Norges Bank has crossed the 3% voting rights threshold, which is vital for all stakeholders. Understanding the Changes in Voting Rights The...

Continue Reading
ZyVersa Therapeutics Marks Progress with Promising Pipeline Updates

Updated Category News Views 232

Key Developments in ZyVersa's Clinical Journey Important Highlights: Announcement of a Phase 2a proof-of-concept clinical trial for Cholesterol Efflux Mediator™ VAR 200 focusing on patients with diabetic kidney disease planned for the first half of 2025. The regulatory framework for VAR 200’s primary indication, focal segmental glomerulosclerosis (FSGS), is set to...

Continue Reading
Bunion Surgery Market Growth and Leading Players Explained

Updated Category News Views 270

Overview of the Bunion Surgery Market The global Bunion Surgery Market is witnessing substantial growth, projected to increase from US$437.8 million in 2023 to an impressive US$606.1 million by 2029, achieving a CAGR of 5.7%. The surge in demand for surgical treatments primarily arises from the rising incidence of bunions, particularly among the aging population who are...

Continue Reading